At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Zenith® Branch Endovascular Graft-Iliac Bifurcation, +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation
In Brief
A clinical study evaluating Zenith® Branch Endovascular Graft-Iliac Bifurcation,, Atrium iCAST™, and 1 other intervention for Aortoiliac Aneurysms and Iliac Aneurysms. Completed, enrolled 40 participants across 28 sites.
Detailed Summary
The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortoiliac Aneurysms, Iliac Aneurysms
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartApr 2014
First PostedOct 2015
Primary CompletionNov 2015
Study CompletionNov 2020
TodayJul 2026
First PostedOct 8, 2015
Enrollment StartApr 1, 2014
Primary CompletionNov 1, 2015
Study CompletionNov 4, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.7 years ago
Interventions
Zenith® Branch Endovascular Graft-Iliac Bifurcation,device
Implantation of the Zenith® Branch Endovascular Graft-Iliac Bifurcation.
Atrium iCAST™device
Implantation of Atrium iCAST
Zenith® Flex AAA Endovascular Graftdevice
Implantation of the Zenith Flex Endovascular Graft